0000899243-23-001360.txt : 20230109 0000899243-23-001360.hdr.sgml : 20230109 20230109190501 ACCESSION NUMBER: 0000899243-23-001360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220108 FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jeynes-Ellis Allison M CENTRAL INDEX KEY: 0001758521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 23519358 MAIL ADDRESS: STREET 1: FLAT 52 STREET 2: WILLIAM HUNT MANSIONS CITY: LONDON STATE: X0 ZIP: SW13 8HT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-08 0 0001098972 AGENUS INC AGEN 0001758521 Jeynes-Ellis Allison M C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Stock Option 2.40 2023-01-08 4 A 0 100000 0.00 A 2033-01-08 Common Stock 100000 100000 D Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024. By: /s/Christine Klaskin as Attorney-in-Fact for Allison Jeynes-Ellis 2023-01-09